| Sr No | Title | Journal |
|---|
| 1. | Reversal of Slow-Flow or No-Reflow during PTCA using boluses of IC adenosine and sodium nitroprusside, in combination | J Am Coll Cardiol 2003;41(6 Suppl. A):561-568 |
| 2. | Reversal of Slow-Flow or No-Reflow during PTCA using boluses of IC adenosine and sodium nitroprusside in combination | J Am Coll Cardiol 2003;41(6 Suppl. A):1101-201. |
| 3. | Beneficial effects of distal protection device in Reducing the use of intracoronary vasodilators And glycoprotein IIb/IIIa receptor antagonists. During percutaneous coronary interventions. | Catheterization and Cardiovascular Interventions 2004; 62: pg 90. (Abstract) |
| 4. | Improvement in mace by sequential administration Of boluses of intracoronary adenosine and sodium. Nitroprusside during percutaneous coronary Interventions .
| Catheterization and Cardiovascular Interventions 2004; 62:130-131 |
| 5. | Effect of Folate Treatment on Homocysteinemia in Cardiac Patients: A Prospective Study | Indian J Pharmacol 2005; 37:13-17. |
| 6 | First in Man: non invasive measurement of variation in Pulmonary artery pressure following exercise in heart failure patients using an innovative implantable device involving acoustic telemetry. | Eur Heart J 2006;27(suppl 1): 827-985 |
| 7. | First In Man: Measurement of Diurnal Variation in Pulmonary Artery Systolic and Diastolic Pressure in Heart Failure Patients Using an Innovative Implantable Device Responding to Ultrasonic Signals | Eur Heart J 2006;27(suppl 1): 291-565. |
| 8. | Effect of Metoprolol CR/XL on Exercise Capacity and Subsequent Variation in Pulmonary Artery Pressure in Heart Failure Patients Using an Innovative Implant Involving Acoustic Telemetry. | Eur Heart J 2006;27(suppl 1): 827-985 |
| 9. | First In Man Non-Invasive Monitoring of Pulmonary Artery Pressure from an Implantable Device Using Acoustic Telemetry: A One Year Follow-Up Data | Eur Heart J 2006;27(suppl 1): 1-290 |
| 10. | Measuring Pulmonary Artery Pressure Non-invasively with Conventional Contrast Echocardiography in Congestive Heart Failure. | Eur Heart J 2006;27(suppl 1): 1-290 |
| 11. | First-in-man: Coronary Sinus Narrowing with a Reducer Stent- A Possible Alternative Percutaneous Treatment for Patients with Refractory Angina | J Am Coll Cardiol 2006;47;1B-56B |
| 12. | First in Human Implanted Device in Pulmonary Artery Using Acoustic Telemetry Based on Non-Invasive Ultrasound Activation and Communication. | J Am Coll Cardiol 2006;47;1B-56B. |
| 13. | Intraconory Boluses of Adenosine and Sodium Nirtoprusside in combination Reverses Slow/No Reflow During Angioplasty: A Clinical Scenario of Experimental Pre-conditioning. | J Am Coll Cardiol 2006;47:381A-384A |
| 14. | Wireless Acoustic Communication With a Miniature Pressure Sensor in the Pulmonary Artery for Disease Surveillance and Therapy of Patients With Congestive Heart Failure | J Am Coll Cardiol 2007;49:784 – 789 |
| 15. | Coronary Sinus Reducer-Stent for the Treatment of Chronic Refractory Angina Pectoris: A prospective, open label, multi-center safety feasibility first-in-man study. | J Am Coll Cardiol 2007;49:1783-1789. |
| 16 | Intracoronary boluses of adenosine and sodium nitroprusside in combination reverses slow/no-reflow during angioplasty: a clinical scenario of ischemic preconditioning. | Can J Physiol Pharmacol 2007;85 (3-4):476-82. |
| 17. | Systemic Primary Aspiration in Acute Myocardial Percutaneous Intervention: A Multicentre Randomized controlled trial of the export aspiration catheter. | Euro Intervention 2008;4:222-228 |
| 18. | Effect of Metoprolol CR/XL on Pulmonary Artery Pressure in Chronic Heart Failure Patients Assessed by an Implanted Ultrasonic Device with Special Emphasis on Diurnal Variation and Exercise Capacity | Indian Heart J 2009;61:34-9 |
| 19. | Ovalum CiTop™ Expander™: a novel guidewire for crossing coronary chronic total occlusions – first-in-man (FIM) experience | EuroIntervention 2009;5:206-211 |
| 20. | Safety and Effectiveness of the Endeavor Zotarolimus-Eluting Stent in Real-World Clinical Practice: Extended 12-Month data from the E-Five Registry | JACC Cardiovasc Interv 2009;2(12):1227-35 |
| 21. | Platelet Inhibition with Cangrelor in Patients Undergoing PCI | N Engl J Med 2009;361:2318-29. |
| 22. | Rationale and design of the Patient Related Outcomes with Endeavor versus Cypher stenting Trial (PROTECT): Randomized controlled trial comparing the incidence of stent thrombosis and clinical events after sirolimus or zotarolimus drug-eluting stent implantation | Am Heart J 2009;158:902-909.e5 |
| 23. | Exercise improvement and plasma biomarker changes with intravenous treprostinil therapy for pulmonary arterial hypertension: A placebo-controlled trial (TRUST – 2) | J Heart Lung Transplant 2010;29(2):137-49 |
| 24. | Ticagrelor Versus Clopidogrel in Acute Coronary Syndromes in Relation to Renal Function Results From the Platelet Inhibition and Patient Outcomes (PLATO) Trial | Circulation 2010;122:1056-1067 |
| 25. | Pre Treatment with thienopyridines reduces the amount of Myonecrosis in acute coronary syndrome patients invasively managed: insights from the champions trials. | Circulation 2010;122:A14183 |
| 26 | Long-Term Follow-Up to Evaluate the Safety of the Neovasc Reducer a Device-Based Therapy for Chronic Refractory Angina.
| J Am Coll Cardiol 2010;55;A98.E927 |
| 27. | Six Month Follow Up Data of Orbital Atherectomy System for the Treatment of De Novo Calcified Coronary Lesions (ORBIT I Trial). | J Am Coll Cardiol 2011;58:B172-B173 |
| 28. | Two Year Follow Up Data of Orbital Atherectomy System for the Treatment of De Novo Calcified Coronary Lesions – A Single Center Experience. | J Am Coll Cardiol 2011;58:B174 |
